Anti-proliferation and molecular docking study of s-triazinyl uracil hybrids

A series of uracil substituted s-triazinyl derivatives (U1T, U2T & U3T) were synthesized. All the hybrids were in vitro evaluated for their anti-proliferative activity in human cancer cell lines, namely HepG2 hepatocellular carcinoma and normal hepatocytes. Docking studies have been performed with suitable enzyme to study the mode of action. The IC₅₀ values of these compounds showed less viability exhibited in tumor cells compare to normal cells. The hybrid molecules distinguish between cancer cell from normal cell and reducing the toxicity. Finally, a theoretical kinetic study was established to predict the ADME of the active hybrids. These compounds are worthy of further evaluation as anticancer agents.

Author(s): M. Karthick, M. Shanmugam and V. Chidambaranathan

Abstract | PDF

Share This Article